management of cancer pain prof. dr. başak oyan-uluç yeditepe Üniversitesi hastanesi medikal...

47
Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Upload: carmella-francis

Post on 13-Jan-2016

237 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Management of Cancer Pain

Prof. Dr. Başak Oyan-UluçYeditepe Üniversitesi Hastanesi

Medikal Onkoloji Bölümü

Page 2: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Cancer pain

At diagnosis % 20-50

During treatment % 30-40

Advanced stage %75-90

Page 3: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Physiological effects of Pain

• Decreased limb movement: increased risk of DVT/PE

• Respiratory effects: shallow breathing, tachypnea, cough suppression resulting increased risk of pneumonia and atelectasis

• Tachycardia and elevated blood pressure

• Increased catabolic demands: poor wound healing, weakness, muscle breakdown

• Increased sodium and water retention (renal)

• Decreased gastrointestinal mobility

Page 4: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Psychological effects of Pain

• Negative emotions: anxiety, depression

• Sleep deprivation

• Existential suffering

• Patient questions the very foundations of their life:

whether their life has any meaning, purpose or

value

Page 5: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Immunological effects of Pain

Decrease natural killer cell counts

Tolerance to chemotherapy decrease. infection

Page 6: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Cancer pain

Physiological effects

Psychological effects

Immunological effects

Decreased quality of life

Shorter survival

Page 7: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

What Does Pain Mean to Patients?

• Poor prognosis or impending death

• Particularly when pain worsens

• Decreased autonomy

• Impaired physical and social function

• Decreased enjoyment and quality of life

• Challenges to dignity

• Threat of increased physical suffering

Page 8: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Causes of Cancer-Related Pain• Tumor / Mass effect (70%)

• Bone metastases, soft tissue infiltration, nerve infiltration

• Treatment related (20%)• Post-chemotherapy• Post-radiation (mucositis, enteritis , etc)• Post-surgical (mucositis, neuropathy, G-CSF related bone

pain, etc)

• Other (10%)– Decubitis ulcers, constipation – Postherpetikc neuralgia

Page 9: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Types of pain

• Somatic pain

• Visceral pain

• Neuropathic pain

Page 10: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Somatic Pain

• Generally described as musculoskeletal pain• Dull, sometimes sharp• Intermittent or continuous• Well-localized: Because many nerves supply the

muscles, bones and other soft tissues, somatic pain is usually easier to locate than visceral pain.

• Related to tumor / mass effect

• Example: Soft tissue infiltration, bone metastases

Page 11: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Patient with head and neck cancer: Large right sided mass causing somatic pain

Page 12: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Visceral Pain

• Infiltration, compression, extension, or stretching of the thoracic, abdominal, or pelvic viscera

• Pressure, deep, squeezing, cramps

• Not well-localized or referred pain

• Intermittent or continuous

• Example: Intraabdominal metastases

Page 13: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Colorectal cancer with liver metastases:Visceral pain

Page 14: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Neuropathic Pain

• Causes:

• Cancer compressing or infiltrating nerves/nerve roots/blood supply to nerve

• Nerve damage from treatments

• Types:

• Dysestetic: Burning, “pins & needles”

• Ex: Postherpetic neuralgia

• Neuralgic: Sharp, shooting and paroxysmal pain along the course of a nerve

• Ex: Trigeminal neuralgia

Page 15: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Neuropathic Pain

• Chemotherapy-induced neuropathies: symmetrical polyneuropathy – localized in hands and feet

• Cisplatin, Oxaliplatin

• Paclitaxel, Thalidomide

• Vincristine, Vinblastine

• Surgical Neuropathies

• Phantom limb pain

• Post-mastectomy syndrome

• Post-thoracotomy syndrome

Page 16: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü
Page 17: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Most cancer pts have some sort of combination of somatic, visceral pain and neuropathic pain

Patient with cervival cancer

• Visceral pain due to peritoneal carcinomatosis

• Somatic pain: Due to vertebral metastasis

• Neuropathic pain from nerve root involvement

Page 18: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Assessment of cancer pain

Page 19: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Assessment of Pain

• Pain history

• Onset / duration

• Severity of paiN

• Site(s) of pain/radiation

• Type of pain

• What aggravates or relieves pain?

• Impact on sleep, mood, activity

• Effectiveness of medication

Page 20: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Non-verbal signs of pain• Autonomic changes

– Hypertension, tachycardia, sweating

• Patients with organic brain syndrome: Agitation or confusion

• Patients with cognitive dysfunction: Apathy, inactivity, irritability– Refuse eating– Avoidance of painful site– Painful expression on face

Page 21: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Principles of Assessment

• A (Ask) Assess and REASSESS

• B (Believe) the patient and care-givers

• C (Choose) Use methods appropriate to cognitive status and context

• D (Deliver)

• E (Empower) Include the family

Page 22: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

• Pain scales– Numeric– categoric– Facial expression pictures

• Body maps

• Pain queries

Assessment of severity of pain

MUST BE FİLLED BY THE PATIENT

Page 23: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

TREATMENT

Page 24: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

MAXIMUM PAIN CONTROL

MINIMUM SIDE EFFECT

INCREASED QUALITY OF LIFE

No pain at rest No pain with activity

No interrruption of sleep due to pain

Aims of Cancer Pain treatment

Page 25: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Modalities of treatment• Pharmacological Management

• Radiation / Nuclear Medicine

• Non-Pharmacologic Management

• Interventions– Blocks– Epidural or intratecal pain pumps– Palliative surgery (ablative neurosurgery)– Nerve Blocks

Page 26: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Pharmacological Treatment

Page 27: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Pharmacologic Management

• WHO Ladder

• Non-opioid therapy / Co-analgesics

• Opioids

Page 28: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

WHO Ladder

(1-3)

(4-6)

(7-10)

Oral

By the clock

Step by step4. Basamak:

Invasive modalities

Page 29: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Non-Opioids NSAIDS Acetaminophen (Paracetamol) Topicals

Lidocaine, Capsaicin

For mild pain Ceiling effect: increasing doses of a given medication to have

progressively smaller incremental effect Can be combined with opioids-> Opioid dose lower No tolerance and no addiction risk

NSAID: Gastointestinal, renal and hematological side effects

Page 30: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Adjuvants

• Primary indication other than pain, but have some analgesic properties in some painful conditions

• Usually coadministered with other analgesics

Benzodiazepines Antispasmodics Muscle relaxants NMDA-blockers Systemic local

anesthetics

Antidepressants Anticonvulsants Corticosteroids Neuroleptics Alpha2 – agonists

Page 31: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Adjuvants for special pain types

• Neuropathic pain: Antidepresants, Anticonvulsants, GABA agonists, etc

• Bone pain: Osteoclast inhibitors (bisfosfonates), radiopharmaceuticals, corticosteroids

• Musculoskeletal pain: Muscle relaxants

Page 32: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

OpioidsStep 2 opioids

Codeine, Oxycodone, tramadol

Step 3 opioids Oxycodone, morphine, fentanyl

AVOID: Meperidine

If pain constant/chronic – use long-acting opioids with short-acting for breakthrough pain

Page 33: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Principles of analgesic treatment• Patient –specifc treatment: Dose, route

• By clock: Analgesics should be administered at regular intervals, not as needed

• Appropriate dose

• Consider renal and liver functions

• When changing to and other opioid or the route of adb-ministration, use “equal analgesic conversions” guides

• Avoid placebo

Page 34: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Principles of analgesic treatment

• Be aware of drug side effects and prevent side effects

• Monitor development of tolerance

• DO NOT USE MEPERİDİNE (Dolantin) for cancer pain– Toxic metabolite is normeperidine –> highserum levels can cause

seizures– Short-acting

Page 35: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Side effects of opioids

Physiological side effectsSedation

Constipation

Nausea-vomiting

Urinary retention

Supression of cough

Toxic side effects

Lethagy

Hallusination

Myoclonik jerks

Supression of respiration

Tolerance to Nausea-vomitingand sedation: Early

Tolerance to constipation: Late

Page 36: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Success rate of Cancer pain Treatment

• Oral /Transdermal• Administer by clock• Step by step• Patient-specific

• Appropriate– Dose– Route– Dose interval

• Treatment of breakthrough pain

• Treatment od side effects

Success rate>%80

Page 37: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Reasons for failure to relieve cancer pain

• Inadequate dose of opioids– No ceiling dose for agonist opioids like morphine

– Only dose-limiting factor: Side effects

• In young patients, dose should be higher

Seminars in Oncology, Vol 27. No.1 February 2000: pp 45-63Seminars in Oncology, Vol 27. No.1 February 2000: pp 45-63

Page 38: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Torkey

Mean: 0.0872

World: Rank number 44

EURO zone Rank number 33

Page 39: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Torkey

Mean: 0.1763

World: Rank number 106

EURO zone Rank number 42

Page 41: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Reason for inadequate doing of opioids?

• Physicians’ lack of information about opioids

• Patients’/Relatives’ lack of information about opioids

• Exaggeration of risks

• Side effects

• Risk of addiction

• Legal factors

Page 42: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Non-Pharmacologic Management

Acupuncture Yoga Guided imagery Cold/heat Massage Vibration TENS units

Exercise programs Hypnosis Music Pet therapy

Page 43: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Intervensions

Palliative surgery

Nerve Blocks

Kyphoplasty/Vertebroplasty

Epidural

Intrathecal pain pumps

Page 44: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Celiac Plexus Block

Page 45: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Kyphoplasty/Vertebroplasty

Page 46: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Intrathecal Pain Pumps

Page 47: Management of Cancer Pain Prof. Dr. Başak Oyan-Uluç Yeditepe Üniversitesi Hastanesi Medikal Onkoloji Bölümü

Conclusion Cancer pain can effect quality of life and mortality

Ask the patient about pain and REASSESS!

Choose non-opioid / adjuvants carefully paying close attention to side effect profile

Use WHO ladder guidelines when titrating pain medications

Use long-acting opioids for chronic cancer pain

Recognize “4th step” in WHO ladder and utilize your multidisciplinary resources